J&J strikes $6.5 billion deal to buy autoimmune disease specialist Momenta Reuters reports.
Reuters. File photo. Johnson & Johnson’s corporate logo is displayed on a screen to celebrate the 75th anniversary of the company’s listing on the New York New York Stock Exchange. By Manas Mishra. (Reuters) – Johnson & Johnson agreed on Wednesday to buy Momenta Pharmaceuticals Inc. for about $6.5Read More →